BIOMAT Database Logo BIOMAT Database Logo

Safety of amlodipine use in patients with acute intermittent porphyria. 2007

Hakan Cinemre, and Ugur Korkmaz, and Aytekin Alcelik, and Elif Onder, and Adem Gungor

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D012449 Safety Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property. Safeties
D017118 Porphyria, Acute Intermittent An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine. Hydroxymethylbilane Synthase Deficiency,Uroporphyrinogen Synthase Deficiency,Acute Porphyria,PBGD Deficiency,Porphobilinogen Deaminase Deficiency,Porphyria, Swedish Type,UPS Deficiency,Acute Intermittent Porphyria,Acute Intermittent Porphyrias,Acute Porphyrias,Deaminase Deficiencies, Porphobilinogen,Deaminase Deficiency, Porphobilinogen,Deficiencies, Hydroxymethylbilane Synthase,Deficiencies, PBGD,Deficiencies, Porphobilinogen Deaminase,Deficiencies, UPS,Deficiencies, Uroporphyrinogen Synthase,Deficiency, Hydroxymethylbilane Synthase,Deficiency, PBGD,Deficiency, Porphobilinogen Deaminase,Deficiency, UPS,Deficiency, Uroporphyrinogen Synthase,Hydroxymethylbilane Synthase Deficiencies,Intermittent Porphyria, Acute,Intermittent Porphyrias, Acute,PBGD Deficiencies,Porphobilinogen Deaminase Deficiencies,Porphyria, Acute,Porphyrias, Acute,Porphyrias, Acute Intermittent,Porphyrias, Swedish Type,Swedish Type Porphyria,Swedish Type Porphyrias,Synthase Deficiencies, Hydroxymethylbilane,Synthase Deficiencies, Uroporphyrinogen,Synthase Deficiency, Hydroxymethylbilane,Synthase Deficiency, Uroporphyrinogen,Type Porphyria, Swedish,Type Porphyrias, Swedish,UPS Deficiencies,Uroporphyrinogen Synthase Deficiencies
D017311 Amlodipine A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION. Amlodipine Besylate,Amlodipine Maleate,Amlodipine Maleate (1:1),Amlodipine, (+-)-Isomer,Amlodipine, (+-)-Isomer, Maleate (1:1),Amlodipine, (R)-Isomer,Amlodipine, (S)-Isomer, Maleate (1:1),Amlodis,Amlor,Astudal,Istin,Norvasc

Related Publications

Hakan Cinemre, and Ugur Korkmaz, and Aytekin Alcelik, and Elif Onder, and Adem Gungor
Amlodipine-induced acute intermittent porphyria exacerbation.
February 1997, The Annals of pharmacotherapy,
Hakan Cinemre, and Ugur Korkmaz, and Aytekin Alcelik, and Elif Onder, and Adem Gungor
Safety of ketamine in patients with acute intermittent porphyria. Case reports.
August 1979, Acta anaesthesiologica Scandinavica,
Hakan Cinemre, and Ugur Korkmaz, and Aytekin Alcelik, and Elif Onder, and Adem Gungor
Drug treatment of hypertension in acute intermittent porphyria: doxazosin and amlodipine.
March 1997, British journal of clinical pharmacology,
Hakan Cinemre, and Ugur Korkmaz, and Aytekin Alcelik, and Elif Onder, and Adem Gungor
[Use of propranolol in acute intermittent porphyria].
December 1973, Der Nervenarzt,
Hakan Cinemre, and Ugur Korkmaz, and Aytekin Alcelik, and Elif Onder, and Adem Gungor
Caring for patients with acute intermittent porphyria.
February 1994, AACN clinical issues in critical care nursing,
Hakan Cinemre, and Ugur Korkmaz, and Aytekin Alcelik, and Elif Onder, and Adem Gungor
Acute intermittent porphyria and epilepsy: safety of clonazepam.
January 1992, Epilepsia,
Hakan Cinemre, and Ugur Korkmaz, and Aytekin Alcelik, and Elif Onder, and Adem Gungor
Hepatocellular carcinoma in patients with acute intermittent porphyria.
January 1984, Acta medica Scandinavica,
Hakan Cinemre, and Ugur Korkmaz, and Aytekin Alcelik, and Elif Onder, and Adem Gungor
Cardiac surgery in patients with acute intermittent porphyria.
May 2012, Journal of cardiac surgery,
Hakan Cinemre, and Ugur Korkmaz, and Aytekin Alcelik, and Elif Onder, and Adem Gungor
[Use of propofol in a patient with acute intermittent porphyria].
January 1989, Annales francaises d'anesthesie et de reanimation,
Hakan Cinemre, and Ugur Korkmaz, and Aytekin Alcelik, and Elif Onder, and Adem Gungor
[Use of propofol in a patient with acute intermittent porphyria].
January 1989, Annales francaises d'anesthesie et de reanimation,
Copied contents to your clipboard!